These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10669638)

  • 21. Fibroblast growth factor-2 transiently activates the p53 oncosuppressor protein in human primary vascular smooth muscle cells: implications for atherogenesis.
    Barillari G; Iovane A; Bonuglia M; Albonici L; Garofano P; Di Campli E; Falchi M; Condò I; Manzari V; Ensoli B
    Atherosclerosis; 2010 Jun; 210(2):400-6. PubMed ID: 20122687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nitric oxide selectively amplifies FGF-2-induced mitogenesis in primary rat aortic smooth muscle cells.
    Hassid A; Arabshahi H; Bourcier T; Dhaunsi GS; Matthews C
    Am J Physiol; 1994 Sep; 267(3 Pt 2):H1040-8. PubMed ID: 8092269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential regulation of protease activated receptor-1 and tissue plasminogen activator expression by shear stress in vascular smooth muscle cells.
    Papadaki M; Ruef J; Nguyen KT; Li F; Patterson C; Eskin SG; McIntire LV; Runge MS
    Circ Res; 1998 Nov; 83(10):1027-34. PubMed ID: 9815150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibroblast growth factor-2-toxin induced cytotoxicity: differential sensitivity of co-cultured vascular smooth muscle cells and endothelial cells.
    Lin PH; Ren D; Hirko MK; Kang SS; Pierce GF; Greisler HP
    Atherosclerosis; 1998 Apr; 137(2):277-89. PubMed ID: 9622271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple growth factors are released from mechanically injured vascular smooth muscle cells.
    Crowley ST; Ray CJ; Nawaz D; Majack RA; Horwitz LD
    Am J Physiol; 1995 Nov; 269(5 Pt 2):H1641-7. PubMed ID: 7503260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blockade of vascular smooth muscle cell proliferation and intimal thickening after balloon injury by the sulfated oligosaccharide PI-88: phosphomannopentaose sulfate directly binds FGF-2, blocks cellular signaling, and inhibits proliferation.
    Francis DJ; Parish CR; McGarry M; Santiago FS; Lowe HC; Brown KJ; Bingley JA; Hayward IP; Cowden WB; Campbell JH; Campbell GR; Chesterman CN; Khachigian LM
    Circ Res; 2003 May; 92(8):e70-7. PubMed ID: 12690039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibroblast growth factor-2 induces osteogenic differentiation through a Runx2 activation in vascular smooth muscle cells.
    Nakahara T; Sato H; Shimizu T; Tanaka T; Matsui H; Kawai-Kowase K; Sato M; Iso T; Arai M; Kurabayashi M
    Biochem Biophys Res Commun; 2010 Apr; 394(2):243-8. PubMed ID: 19903460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coordinated effects of fibroblast growth factor-2 on expression of fibrillar collagens, matrix metalloproteinases, and tissue inhibitors of matrix metalloproteinases by human vascular smooth muscle cells. Evidence for repressed collagen production and activated degradative capacity.
    Pickering JG; Ford CM; Tang B; Chow LH
    Arterioscler Thromb Vasc Biol; 1997 Mar; 17(3):475-82. PubMed ID: 9102165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Smooth muscle cell proliferation induced by oxidized LDL-borne lysophosphatidylcholine. Evidence for FGF-2 release from cells not extracellular matrix.
    Chai YC; Binion DG; Macklis R; Chisolm GM
    Vascul Pharmacol; 2002 Apr; 38(4):229-37. PubMed ID: 12449019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of transiently altered sarcolemmal membrane permeability and basic fibroblast growth factor release in the hypertrophic response of adult rat ventricular myocytes to increased mechanical activity in vitro.
    Kaye D; Pimental D; Prasad S; Mäki T; Berger HJ; McNeil PL; Smith TW; Kelly RA
    J Clin Invest; 1996 Jan; 97(2):281-91. PubMed ID: 8567946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Culture-induced increase in acidic and basic fibroblast growth factor activities and their association with the nuclei of vascular endothelial and smooth muscle cells.
    Speir E; Sasse J; Shrivastav S; Casscells W
    J Cell Physiol; 1991 May; 147(2):362-73. PubMed ID: 1710230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of fibroblast growth factor 2 intracellular processing: a kinetic analysis of the role of heparan sulfate proteoglycans.
    Sperinde GV; Nugent MA
    Biochemistry; 2000 Apr; 39(13):3788-96. PubMed ID: 10736179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of vascular cell growth kinetics by local cytokine delivery from fibrin glue suspensions.
    Shireman PK; Hampton B; Burgess WH; Greisler HP
    J Vasc Surg; 1999 May; 29(5):852-61; discussion 862. PubMed ID: 10231637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PDGF-BB induces vascular smooth muscle cell expression of high molecular weight FGF-2, which accumulates in the nucleus.
    Pintucci G; Yu PJ; Saponara F; Kadian-Dodov DL; Galloway AC; Mignatti P
    J Cell Biochem; 2005 Aug; 95(6):1292-300. PubMed ID: 15962299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autocrine FGF signaling is required for vascular smooth muscle cell survival in vitro.
    Miyamoto T; Leconte I; Swain JL; Fox JC
    J Cell Physiol; 1998 Oct; 177(1):58-67. PubMed ID: 9731745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. VEGF regulates FGF-2 and TGF-beta1 expression in injury endothelial cells and mediates smooth muscle cells proliferation and migration.
    Li D; Zhang C; Song F; Lubenec I; Tian Y; Song QH
    Microvasc Res; 2009 Mar; 77(2):134-42. PubMed ID: 18948122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of basic fibroblast growth factor and fibroblast growth factor receptor genes in cultured rat aortic smooth muscle cells.
    van Neck JW; Medina JJ; Onnekink C; Schwartz SM; Bloemers HP
    Biochim Biophys Acta; 1995 Apr; 1261(2):210-4. PubMed ID: 7711064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparan sulphate glycosaminoglycans derived from endothelial cells and smooth muscle cells differentially modulate fibroblast growth factor-2 biological activity through fibroblast growth factor receptor-1.
    Berry D; Shriver Z; Natke B; Kwan CP; Venkataraman G; Sasisekharan R
    Biochem J; 2003 Jul; 373(Pt 1):241-9. PubMed ID: 12659634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of vascular smooth muscle cell proliferation by a novel fibroblast growth factor receptor antagonist.
    Segev A; Aviezer D; Safran M; Gross Z; Yayon A
    Cardiovasc Res; 2002 Jan; 53(1):232-41. PubMed ID: 11744033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extrinsic tension results in FGF-2 release, membrane permeability change, and intracellular Ca++ increase in immature cranial sutures.
    Yu JC; Lucas JH; Fryberg K; Borke JL
    J Craniofac Surg; 2001 Jul; 12(4):391-8. PubMed ID: 11482627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.